Article
Designing Insulin Analogues with Lower Binding Affinity to Insulin Receptor than That of Insulin Icodec
2024-04-29
Abstract excerpt
Insulin therapy is a cornerstone in the management of diabetes, yet the pursuit of optimizing its pharmacokinetic profile remains a focal point in diabetes research. For instance, insulin icodec of Novo Nordisk is a novel long-acting insulin analogue that exhibits an extended duration of action, providing a promising once-weekly treatment option for diabetic patients. However, designing insulin analogues with lowe...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ddde9cb0-6c98-5387-8cd9-506c3070dddf
- DOI
- 10.20944/preprints202404.1922.v1
